Balixafortide (a CXCR4 Antagonist) Plus Eribulin in HER2-negative Metastatic Breast Cancer (MBC): A Phase I Open-Label TrialP. A. Kaufman,S. Pernas,M. Martin,M. Gil-Martin,P. Gomez Pardo, L. T. Sara,L. Manso,E. Ciruelos,J. A. Perez-Fidalgo,C. Hernando,F. O. Ademuyiwa,K. Weilbaecher,I. Mayer,T. J. Pluard,M. Martinez Garcia,L. Vahdat,A. Wach,D. Barker,B. Romagnoli,J. CortesEuropean journal of cancer（2018）引用 1|浏览83暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
